MOGAD的神经心理影响:一位患者报告了研究结果
Bruna Leles1, Yihan Zhang1, Philippe A Bilodeau2
1Department of Neurology, Massachusetts General Brigham, Boston, MA, USA.
Multiple sclerosis and related disorders
|December 20, 2025
概括
患者报告的结果测量 (PROMs) 是可行的,对于氨酸寡干细胞糖蛋白抗体相关疾病 (MOGAD). 这项研究强调了MOGAD患者持续的疲劳,情绪和视觉问题.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 患者报告的结果
背景情况:
- 髓寡细胞糖蛋白抗体相关疾病 (MOGAD) 是一种中枢神经系统自身免疫性脱髓化疾病.
- 虽然急性MOGAD结果已被记录,但对患者健康的长期影响尚未得到充分研究.
研究的目的:
- 评估在MOGAD中使用患者报告结果措施 (PROMs) 的可行性.
- 描述MOGAD患者12个月生活质量,认知,疲劳,焦虑,抑郁和视力方面的变化.
主要方法:
- 招募了22名MOGAD成年人,并在12个月的时间内定期完成PROM.
- PROM包括全球健康,认知,抑郁,焦虑,疲劳和视力方面的措施.
- 统计分析检查了纵向变化和与临床因素的关联.
主要成果:
- 在MOGAD中实施PROM是可行的.
- 在大多数PROM中没有观察到显著的纵向变化.
- 在一些患者中注意到焦虑和抑郁症得分升高,一些得分随着时间的推移而恶化.
结论:
- 在MOGAD中常规使用PROM得到了可行性和确定患者报告的持续性问题的支持.
- 这些发现强调了在MOGAD护理中监测疲劳,情绪和视觉功能的重要性.
更多相关视频
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.2K
09:14Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
866
相关概念视频
Methods of Documentation II: POMR
1.3K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.3K
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
